# Expressive Writing for COVID-19 Resilience

> **NCT04589104** · NA · COMPLETED · sponsor: **Duke University** · enrollment: 63 (actual)

## Conditions studied

- Distress Due to COVID-19

## Interventions

- **BEHAVIORAL:** Expressive writing

## Key facts

- **NCT ID:** NCT04589104
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-26
- **Primary completion:** 2020-08-17
- **Final completion:** 2020-08-17
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04589104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04589104, "Expressive Writing for COVID-19 Resilience". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04589104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*